Advertisement
Screener

Enovis Corp (ENOV) Overview

Enovis Corp (ENOV) Overview

  • 4 Apr 2026: Period ending 3 Jul 2026; Estimate (m); Actual -0.02; Beat / miss (m).
  • 1 Jan 2026: Period ending 3 Apr 2026; Estimate (m); Actual -0.15; Beat / miss (m).
  • 5 Jul 2025: Period ending 3 Oct 2025; Estimate (m); Actual -9.99; Beat / miss (m).
  • 5 Apr 2025: Period ending 4 Jul 2025; Estimate (m); Actual -0.64; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$16.91$19.50$22.49$25.94$29.92$34.512025-09-292026-09-29$16.91$23.92$33.83$47.85$67.68$95.732021-09-292026-09-29$16.91$23.92$33.83$47.85$67.68$95.732016-09-292026-09-29$8.84$15.26$26.34$45.46$78.46$135.402008-05-082026-09-29$8.84$15.26$26.34$45.46$78.46$135.402008-05-082026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$18.46
Previous close
$18.16
Change
$0.30
Change (%)
1.65%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

ENOV
-30.71%
S&P 500
(m)

1 year

ENOV
-38.83%
S&P 500
(m)

3 years

ENOV
-64.99%
S&P 500
(m)

5 years

ENOV
-76.95%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

3 Jul 2026 ○ Estimate (m) ● Actual -0.02

-10.07-7.51-4.96-2.400.164 Apr 2025: estimate (m); actual -0.984 Apr 2025(m)4 Jul 2025: estimate (m); actual -0.644 Jul 2025(m)3 Oct 2025: estimate (m); actual -9.993 Oct 2025(m)3 Apr 2026: estimate (m); actual -0.153 Apr 2026(m)3 Jul 2026: estimate (m); actual -0.023 Jul 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
4 Apr 20263 Jul 2026(m)-0.02(m)(m)
1 Jan 20263 Apr 2026(m)-0.15(m)(m)
5 Jul 20253 Oct 2025(m)-9.99(m)(m)
5 Apr 20254 Jul 2025(m)-0.64(m)(m)
1 Jan 20254 Apr 2025(m)-0.98(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -20.75

-20.83-15.23-9.63-4.021.5831 Dec 2021: estimate (m); actual 1.4031 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.2531 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.6131 Dec 2023(m)31 Dec 2024: estimate (m); actual -14.9331 Dec 2024(m)31 Dec 2025: estimate (m); actual -20.7531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-20.75(m)(m)
1 Jan 202431 Dec 2024(m)-14.93(m)(m)
1 Jan 202331 Dec 2023(m)-0.61(m)(m)
1 Jan 202231 Dec 2022(m)-0.25(m)(m)
1 Jan 202131 Dec 2021(m)1.40(m)(m)

Revenue vs. Earnings

USD

3 Jul 2026 ■ Revenue 582.78M ■ Earnings -1.19M — Profit margin -0.20%

-710.38M-105.1%-230.79M-69.8%248.80M-34.5%728.39M0.8%3 Oct 2025: revenue 548.91M; earnings -571.15M; profit margin -104.05%3 Oct 202531 Dec 2025: revenue 575.76M*; earnings -520.59M*; profit margin -90.42%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-04 to 2025-12-31; USD.31 Dec 20253 Apr 2026: revenue 589.15M; earnings -8.76M; profit margin -1.49%3 Apr 20263 Jul 2026: revenue 582.78M; earnings -1.19M; profit margin -0.20%3 Jul 2026

31 Dec 2025 ■ Revenue 2.25B ■ Earnings -1.18B — Profit margin -52.69%

-1.60B-53.7%-0.18B-35.7%1.24B-17.8%2.66B0.1%31 Dec 2022: revenue 1.56B; earnings -0.01B; profit margin -0.85%31 Dec 202231 Dec 2023: revenue 1.71B; earnings -0.03B; profit margin -1.95%31 Dec 202331 Dec 2024: revenue 2.11B; earnings -0.83B; profit margin -39.17%31 Dec 202431 Dec 2025: revenue 2.25B; earnings -1.18B; profit margin -52.69%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$18.46(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$18.46High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning ENOV

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.26M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.38%*
Total return · month
-25.86%*
Total return · quarter
-16.17%*
Total return · half year
-15.40%*
Total return · year to date
-30.71%*
Total return · 1 year
-38.83%*
Total return · 3 years
-64.99%*
Total return · 5 years
-76.95%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Enovis Corp Overview

View more →

(m)

(m)

SEC CIK
1420800
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
2900 LAKE VISTA DRIVE, SUITE 200, LEWISVILLE, Texas, 75067, United States
Fiscal year end
1231
Phone
(302) 252-9160

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85